Artificial Blood for Dogs

Area of Science:

• Biotechnology
• Veterinary Medicine
• Biochemistry

Background:

• The absence of dedicated pet blood banks necessitates veterinary self-sufficiency in obtaining blood products for transfusions.
• Serum albumin and red blood cells (RBCs) are critical blood components for life-saving interventions in animals.

Purpose of the Study:

• To synthesize and characterize artificial blood components for canine transfusion therapy.
• To develop recombinant canine serum albumin (rCSA) and an artificial oxygen carrier (Hb-rCSA3).

Main Methods:

• Recombinant canine serum albumin (rCSA) produced using Pichia yeast genetic engineering.
• Crystal structure determination of rCSA at 3.2 Å resolution.
• Synthesis of hemoglobin-albumin cluster (Hb-rCSA3) as an RBC substitute and oxygen carrier.

Main Results:

• rCSA exhibited identical features to native canine plasma albumin.
• The crystal structure of rCSA was successfully determined.
• Hb-rCSA3 demonstrated a suitable negative surface charge (pI = 4.7) and high oxygen-binding affinity (P50 = 9 Torr).

Conclusions:

• Pure rCSA is suitable for broad clinical and pharmaceutical applications.
• Hb-rCSA3 functions effectively as an oxygen carrier and is a promising alternative for RBC transfusion in veterinary medicine.
• This artificial blood offers potential solutions for critical care in various veterinary situations.